Tong Ren Tang Technologies Co. Ltd.

HKSE 1666.HK

Tong Ren Tang Technologies Co. Ltd. EBT Margin for the year ending December 31, 2023: 17.16%

Tong Ren Tang Technologies Co. Ltd. EBT Margin is 17.16% for the year ending December 31, 2023, a -15.16% change year over year. EBT Ratio (Earnings Before Tax Ratio) is the fraction of earnings before taxes to total revenue, indicating the company's profitability before the impact of tax expenses.

Tong Ren Tang Technologies Co. Ltd. EBT Margin for the year ending December 31, 2022 was 20.23%, a 4.53% change year over year.
Tong Ren Tang Technologies Co. Ltd. EBT Margin for the year ending December 31, 2021 was 19.35%, a -5.11% change year over year.
Tong Ren Tang Technologies Co. Ltd. EBT Margin for the year ending December 31, 2020 was 20.39%, a -1.15% change year over year.
Tong Ren Tang Technologies Co. Ltd. EBT Margin for the year ending December 31, 2019 was 20.63%, a -13.52% change year over year.

Key data

Date	EBT Margin	Net Income Margin	EBITDA Margin	EBIT Margin

HKSE: 1666.HK

Tong Ren Tang Technologies Co. Ltd.

CEO	Mr. Jia Fu Chen
IPO Date	Oct. 31, 2000
Location	China
Headquarters	No. 20 Nansanhuan Zhonglu Road
Employees	4,005
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Cleaning Supplies Consumer Packaged Goods Cosmetics Drugstores & Retail Pharmacies Perfumes & Fragrances Personal Care

Description

Tong Ren Tang Technologies Co. Ltd. manufactures and sells Chinese medicine products in Mainland China and Hong Kong. The company also cultivates, purchases, and sells Chinese medicinal raw materials; produces and sells ointment, tea drinks, and foot care products; sells medicinal products; and provides medical research and development, advertisement, and Chinese medical consultation and treatment services. In addition, it is involved in the technological development and sale of biological products, Chinese and Western medicines, cosmetics, and healthcare products; wholesale and retail sale of Chinese medicines and healthcare products; and internal and external surgery, medical examination, and hospital management activities. Further, it produces and processes biochemical products; extracts and processes plants; and produces food and daily chemical products, and medical services. The company was founded in 1669 and is based in Beijing, the People's Republic of China.

Key trends

Past 5 years